1. "Breast Medicine Service"
Formats
  1. Journal Article (2170)
  2. Meeting Abstract (1650)
  3. Review (78)
  4. Book Section (67)
  5. Editorial (42)
  6. Conference Paper (28)
  7. Guidelines (26)
  8. Correspondence (16)
  9. Miscellaneous (11)
  10. Research Letter (10)
  11. Book Whole (5)
Groups
  1. Breast Medicine Service (4103)
  2. Department of Medicine (4103)
  3. Solid Tumor Oncology Division (4103)
  4. Survivorship Research (2337)
  5. GSK Faculty (1492)
  6. Population Sciences Research Program (1339)

More Groups

People
  1. Clifford Hudis (905)
  2. Larry Norton (758)
  3. Mark Robson (676)
  4. Neal Rosen (425)
  5. Andrew Seidman (318)
  6. Kenneth Offit (300)

More People

Years
  1. 2025 (57)
  2. 2024 (192)
  3. 2023 (168)
  4. 2022 (219)
  5. 2021 (236)
  6. 2020 (250)

More Years

Publications
  1. Journal of Clinical Oncology (802)
  2. Cancer Research (481)
  3. Breast Cancer Research and Treatment (169)
  4. Annals of Oncology (158)
  5. Clinical Cancer Research (128)
  6. Cancer (78)

More Publications

Publishers
  1. American Society of Clinical Oncology (853)
  2. American Association for Cancer Research (749)
  3. Springer (329)
  4. Elsevier Inc. (322)
  5. Oxford University Press (278)
  6. Nature Publishing Group (273)

More Publishers

Results (4103)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Imlunestrant with or without abemaciclib in advanced breast cancer
    Journal Article

    Jhaveri, K. L.; Neven, P.; Casalnuovo, M. L.; Kim, S. B.; Tokunaga, E.; Aftimos, P.; Saura, C.; O'Shaughnessy, J.; Harbeck, N.; Carey, L. A.; more...
    New England Journal of Medicine (2025)

    Fulltext@MSK | Save
  • Adjuvant dose-dense chemotherapy in hormone receptor-positive breast cancer
    Journal Article

    Metzger Filho, O.; Ballman, K.; Campbell, J.; Liu, M.; Ligibel, J.; Watson, M.; Chen, E.; Du, L.; Stover, D.; Carey, L.; more...
    Journal of Clinical Oncology (2025)

    Fulltext@MSK | Save
  • Inavolisib plus letrozole or fulvestrant in PIK3CA-mutated, hormone receptor-positive, HER2-negative advanced or metastatic breast cancer (GO39374): An open-label, multicentre, dose-escalation and dose-expansion phase 1/1b study
    Journal Article

    Bedard, P. L.; Jhaveri, K. L.; Accordino, M. K.; Cervantes, A.; Gambardella, V.; Hamilton, E.; Italiano, A.; Kalinsky, K.; Krop, I. E.; Oliveira, M.; more...
    European Journal of Cancer (2025)

    Fulltext@MSK | Save
  • Correlation analysis of invasive disease-free survival and overall survival in a real-world population of patients with HR+/HER2– early breast cancer
    Journal Article

    Graff, S. L.; Tolaney, S. M.; Hart, L. L.; Razavi, P.; Janni, W.; Schwartzberg, L. S.; Danyliv, A.; Akdere, M.; Ferrusi, I.; Adhikary, R. R.; more...
    Cancer (2025)

    Fulltext@MSK | Save
  • Pregnancy-specific glycoproteins as potential drug targets for female lung adenocarcinoma patients
    Journal Article

    Oh, J. H.; Rizzuto, G.; Elkin, R.; Weistuch, C.; Norton, L.; Dveksler, G.; Deasy, J. O.
    Briefings in Functional Genomics (2025)

    Fulltext@MSK | Save
  • Impact of adding palbociclib on treatment adherence to ongoing adjuvant endocrine treatment in the global randomized PALLAS randomized trial in patients with early breast cancer
    Journal Article

    Shinn, E.; Zahrieh, D.; DeMichele, A.; Zdenkowski, N.; Lemieux, J.; Mao, J.; Bjelic-Radisic, V.; Naughton, M. J.; Pfeiler, G.; Gelmon, K.; more...
    Breast Cancer Research and Treatment (2025)

    Fulltext@MSK | Save
  • Real-world risk of recurrence and treatment outcomes with adjuvant endocrine therapy in patients with stage II-III HR+/HER2- early breast cancer
    Journal Article

    O'Shaughnessy, J.; Tolaney, S. M.; Yardley, D. A.; Hart, L.; Razavi, P.; Fasching, P. A.; Janni, W.; Schwartzberg, L.; Kim, J.; Akdere, M.; more...
    Breast (2025)

    Fulltext@MSK | Save
  • Treatment patterns and outcomes in HER2-low metastatic breast cancer patients previously treated with chemotherapy: A US real-world cohort study
    Journal Article

    Modi, S.; Zhang, S.; Byng, D.; Hunter, S.; Strübing, A.; Xiong, Y.; Dunton, K.; Mbanya, Z.; Jacot, W.
    Breast Cancer Research and Treatment (2025)

    Fulltext@MSK | Save
  • Enhancing the persistence and anti-tumor efficacy of CAR-T and CAR-NK cells through genetic disruption of death receptors
    Meeting Abstract

    Cohen, T. D.; Yi, F.; Zumbo, P.; Etilib, R.; Arkin, H.; Gormally, M.; Hackett, C. S.; Kropp, K.; Etxeberria, I.; Chandran, S. S.; more...
    Transplantation and Cellular Therapy (2025)

    Fulltext@MSK | Save
  • Healthcare systems-based exercise oncology programs: Emphasizing and speaking the language of the clinic and patient
    Journal Article

    Gorzelitz, J. S.; Kennedy, M. A.; Dittus, K.; Mansfield, S.; Wonders, K.; Hansen, P. A.; Coletta, A. M.; Iyengar, N. M.; Wood, K. C.; Schwartz, A. L.; more...
    Translational Journal of the American College of Sports Medicine (2025)

    Fulltext@MSK | Save